Biggest News Aggregation in the World
📰 Michaelr Cook News

Michaelr Cook News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Michaelr Cook. Real-time updates on events, politics, business and more.

Dr Cook on Real-World Data With Bridging Therapy and Axi-Cel in Relapsed/Refractory LBCL

Michael R. Cook, MD, discusses real-world data associated with the utilization of bridging therapy prior to treatment with axicabtagene ciloleucel in patients with relapsed/refractory large B-cell lymphoma.
Michaelr Cook Abramson Cancer Center Penn Presbyterian Real World Data With Bridging Therapy Penn Medicine Ash Annual Meeting And Exposition Onclive Tv

Addition of Bridging Therapy to Axi-Cel Produces Comparable Real-World Outcomes in R/R LBCL

Although the use of bridging therapy prior to treatment with axicabtagene ciloleucel did not improve efficacy or safety outcomes for patients with relapsed/refractory large B-cell lymphoma, responses to bridging therapy may be prognostic of favorable outcomes after axi-cel administration.
United States University Of Pennsylvania Michaelr Cook Marrow Transplant Research Perelman School Of Medicine International Blood

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science